Galapagos (Netherlands)

Galapagos (Netherlands)

Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Galapagos (Netherlands), Netherlands, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

64%


Total
Publications

185


Total Open
Publications

118


Total
Citations

3.6K


Open Access
Percentage

64%


Total
Publications

185


Total Open
Publications

118


Total
Citations

3.6K

Wikipedia

Website

download

Breakdown

36% 22% 6% 36%

Publisher Open

36%

Both

22%

Other Platform Open

6%

Closed

36%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

05101520253035Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

21%OA Journal

OA Journal 21%

23

Hybrid 29%

31

No Guarantees 50%

53

Other Platform Open

Domain 75%

39

Institution 44%

23

Public 23%

12

Other Internet 8%

4

Preprint 4%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
39
Europe PMC
Domain
12
Figshare
Public
8
Semantic Scholar
Public
6
University of Zurich - Zurich Open Repository and Archive
Institution
5
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System
Institution
4
Erasmus University Rotterdam - EUR Research Repository
Institution
3
whiterose.ac.uk OAI-PMH Repository
Institution
2
University of Oxford - Oxford University Research Archive (ORA)
Institution
2
University of New South Wales, Sydney, Australia - UNSWorks
Institution
2
1 / 4

Data updated 7 April 2025

Share

Share

Share